Risk Evaluation and Mitigation Strategy (REMS) Programs to Promote Appropriate Medication Use and Knowledge: Physician Surveys on Experiences with REMS Programs
OMB Control Number: 0910-0847
Expiration Date: 12/31/2022
[FIRST NAME] [LAST NAME]
[ADDRESS]
[CITY], [STATE] [ZIP]
[MONTH] [DAY], 2021
Dear Dr. [LAST NAME]:
Your participation is voluntary. Your responses will be completely anonymous and analyzed only in the aggregate. Any links between your identity and your responses will be maintained securely by Luminas and will never be released to the research team or FDA.
If you prefer, you can complete the survey online using the following Internet address: [URL]
If you have any questions about this survey, please don’t hesitate to email Dr. Roz Pierson at roz.pierson@luminasllc.com.
Please help us with this important public health objective by completing this survey!
Sincerely,
Ameet Sarpatwari, Ph.D., J.D.
Assistant Professor of Medicine at Harvard Medical School
Division of Pharmacoepidemiology and Pharmacoeconomics
Brigham and Women's Hospital
1620 Tremont St, Suite 3030
Boston MA 02120
1According to the Paperwork Reduction Act of 1995, an agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a valid OMB control number. The valid OMB control number for this information collection is 0910-0847. The time required to complete this information collection is estimated to average 2 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information.
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Mayookha Mitra-Majumdar |
File Modified | 0000-00-00 |
File Created | 2022-06-06 |